The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Predicting the Likelihood of Remission in Children With Graves’ Disease: A Prospective, Multicenter Study
Abstract
OBJECTIVE. The optimal treatment for Graves’ disease in children is controversial. Antithyroid medications are often used initially, but many children eventually require alternative therapies. We evaluated predictors of remission after 2 years of antithyroid medication use. METHODS. We prospectively studied children who had Graves’ disease and were treated with antithyroid medications. We compared children who achieved remission after 2 years with those who had persistent disease to determine which variables were associated with remission; multiple logistic regression and binary recursive partitioning analyses were used to evaluate interactions among predictive variables. RESULTS. Of 51 children who completed the study, 15 (29%) achieved remission. Children who achieved remission had lower thyroid hormone concentrations at presentation than those with persistent disease (free thyroxine: 6.17 ± 3.10 vs 9.86 ± 7.54 ng/dL; total triiodothyronine: 431 ± 175 vs 561 ± 225 ng/dL). Children who achieved remission were also more likely to be euthyroid within 3 months of initiating propylthiouracil (82% vs 29%). Binary recursive partitioning analysis identified rapid achievement of euthyroid status after initiation of propylthiouracil, lower initial triiodothyronine, and older age as significant predictors of remission. CONCLUSIONS. Thyroid hormone concentrations at diagnosis, age, and initial response to propylthiouracil can be used to stratify patients according to the likelihood of remission after 2 years of antithyroid medication use. These data provide a useful guide for clinical decision-making regarding Graves’ disease in children.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In children, when ATDs are used for 1-2 years, remission rates are generally 20%-30%, with remission defined as being euthyroid for 1 year after cessation of therapy (333,339,340).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [339]
In the citing paper
“In another large cohort of 184 medically treated children, after 1 year of therapy with ATDs, 10% were in remission; after 2 years, 14%; after 3 years, 20%; and after 4 years, 23% (339,342).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [339]
In the citing paper
“Retrospective studies have suggested that the chance of remission after 2 years of ATDs is low if the thyroid gland is large (more than 2.5 times normal size for age), the child is young (<12 years) or not Caucasian, serum TRAb levels are above normal on therapy, or free T 4 levels are substantially elevated at diagnosis (>4 ng/dL, 50 pmol/L) (339).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [339]
In the citing paper
“Although two decades ago it was suggested that 25% of children with GD go into remission with every 2 years of continued treatment (341), other studies of larger cohorts of pediatric patients with GD treated with ATDs for extended periods have not revealed similar remission rates (333,339,342).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [339]
In the citing paper
“When RAI activities >150 lCi/g (>5.55 MBq/g) are administered, hypothyroidism rates are about 95% (88,339,349).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [339]
Citations
Cites
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
Methodologic Standards for the Development of Clinical Decision Rules in Emergency Medicine
STIELL, I., & WELLS, G. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70309-4 · Cited by 571
The Efficacy of Thyroidectomy for Graves' Disease: A Meta-analysis
Palit, T. K., Miller, C. C., & Miltenburg, D. M. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5875 · Cited by 246
Agranulocytosis Associated with Antithyroid Drugs: Effects of Patient Age and Drug Dose
COOPER, D. S., GOLDMINZ, D., LEVIN, A. A., LADENSON, P. W., DANIELS, G. H., MOLITCH, M. E., & RIDGWAY, E. C. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-26 · Cited by 245
Read, C. H., Tansey, M. J., & Menda, Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031223 · Cited by 204
LIPPE, B. M., LANDAW, E. M., & KAPLAN, S. A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1241 · Cited by 192
Thyrotoxicosis in Prepubertal Children Compared with Pubertal and Postpubertal Patients
Lazar, L., Kalter-Leibovici, O., Pertzelan, A., Weintrob, N., Josefsberg, Z., & Phillip, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6922 · Cited by 162
Management of Hyperthyroidism in Children and Adolescents
HAMBURGER, J. I. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-5-1019 · Cited by 161
An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine
Rivkees, S. A., & Dinauer, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1239 · Cited by 158
Fifty Years of Experience with Propylthiouracil-Associated Hepatotoxicity: What Have We Learned?
Williams, K. V., Nayak, S., Becker, D. J., Reyes, J., & Burmeister, L. A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.4011 · Cited by 143
Research works printed but not linked: 2
- Baker B, Shapiro B, Fig L, Woodbury D, Sisson J, Beierwaltes W. Unusual complications of antithyroid drug therapy: four case reports and review of literature. Thyroidology.1989;1(1):17–26
- Marcocci C, Marion M. Thyroid directed antibodies. In: Braverman L, Utiger R, eds. The Thyroid. Philadelphia, PA: Lippincott Williams & Wilkins;2005:360–372
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children
Rivkees, S. A., & Szarfman, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2546 · Cited by 177
Kaguelidou, F., Alberti, C., Castanet, M., Guitteny, M.-A., Czernichow, P., & Léger, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0842 · Cited by 173
Metadata
- Authors
- Glaser, N. S., Styne, D. M., & for the Organization of Pediatric Endocrinologists of Northern California Collaborative Graves’ Disease Study Group
- Affiliations
- University of California, Davis (US)
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-03-01
- Volume
- 121
- Issue
- 3
- Pages
- e481-e488
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2080637533
- Cited by
- 125
- References
- 32
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 8 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 6 · 2016: 7 · 2015: 8 · 2014: 10 · 2013: 8 · 2012: 9
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Quest Diagnostics
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- Graves' disease, pediatric Graves' disease, remission prediction, antithyroid drugs, propylthiouracil, thyroid hormone levels, free thyroxine, triiodothyronine, euthyroid status, prognostic factors, age
- MeSH terms
- Adolescent, Age Factors, Child, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Graves Disease, Humans, Male, Predictive Value of Tests, Propylthiouracil, Prospective Studies, Severity of Illness Index, Sex Factors, Antithyroid Agents, Thyroid Function Tests, Multivariate Analysis, Logistic Models, Treatment Outcome, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
